US · Healthcare · Medical Care Facilities
EPS came in at 1.97 against a street estimate of -2.01 — a beat of 198.0%.
Analysts rate agilon health Inc a buy (5 buy, 9 hold, 1 sell out of 15) with an average price target of $115.83.
| Fund | Stake |
|---|---|
| Clayton Dubilier & Rice LLC | 23.82% |
| Morgan Stanley - Brokerage Accounts | 11.98% |
| North Peak Capital Management, LLC | 8.84% |
| BlackRock Inc | 6.83% |
| AQR Capital Management LLC | 4.12% |
| The Goldman Sachs Group Inc | 4.09% |
| Vanguard Capital Management, LLC | 3.13% |
| Marshall Wace Asset Management Ltd | 2.79% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 HEADLINE NUMBERS • Third-quarter 2026 total revenue was $1,519,486 thousand, up from $1,435,321 thousand in the third quarter of 2025. • Third-quart | 2026-11-04 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Third-quarter 2026 revenue was $1.52 billion, up 6% from $1.44 billion in the third quarter of 2025. • Net income was $35 million | 2026-11-04 |
| Quarterly report · Q2 2026 AGILON HEALTH, INC. – FORM 10-Q SUMMARY (Q2 2026) HEADLINE NUMBERS • Net income (6M 2026): $66.9 million vs. net loss of $92.3 million (6M 2025) — m | 2026-08-05 |
| Results announced · Q3 2026 AGILON HEALTH Q2 2026 RESULTS SUMMARY HEADLINE NUMBERS • Total revenues: $1.49 billion in Q2 2026, up 7% from $1.39 billion in Q2 2025 • Net income: | 2026-08-05 |
| Board / officer change · Q3 2026 AGILON HEALTH, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Cash severance payment to departing CTO: $766,063.00 (paid in installments over 12 months | 2026-07-22 |
| Shareholder vote results · Q2 2026 AGILON HEALTH, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Annual stockholder meeting held June 2, 2026 • Company trades on NYSE under ticker symbol | 2026-06-03 |
| Quarterly report · Q1 2026 AGILON HEALTH, INC. - Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Total Revenues (Q1 2026): $1,420.5 million (down from $1,532.8 million in Q1 2025; -7. | 2026-05-06 |
| Results announced · Q2 2026 AGILON HEALTH Q1 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Total Revenue: $1,420 million in Q1 2026, down 7% from $1,533 million in Q1 2025 • Net Inc | 2026-05-06 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Split | 1 : 25 effective Mar 31, 2026 | 2026-03-31 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for agilon health Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.